Increased plasma MCP‐1 and CCR2 on monocytes in COVID‐19 patients and COPLA donors strongly suggest that SARS‐CoV‐2 specifically target this population and is responsible for keeping a sustained inflammatory environment even after clearance of this virus.26 The gene discussed is CCL2; the disease is COVID-19.